⌘K

Home/Filings/4/0000950170-25-034648

4//SEC Filing

Machatha Stephen 4

Accession 0000950170-25-034648

CIK 0001341235other

View on SEC.gov Company Profile

Filed

Mar 5, 7:00 PM ET

Accepted

Mar 6, 4:13 PM ET

Size

5.5 KB

Accession

0000950170-25-034648

Insider Transaction Report

Form 4

Period: 2025-03-04

Aldeyra Therapeutics, Inc.ALDX

Machatha Stephen

Chief Development Officer

Transactions

Award
Stock Option (right to buy)
2025-03-04+202,427→ 202,427 total
Exercise: $6.17Exp: 2035-03-03→ Common Stock (202,427 underlying)

Footnotes (1)

[F1]The shares subject to this option shall vest in equal monthly installments over the next 48 months of continuous service to the Issuer after January 1, 2025.

Documents

1 file

4
ownership.xmlPrimary
4

Issuer

Aldeyra Therapeutics, Inc.

CIK 0001341235

Entity typeother

Related Parties

1

filerCIK 0001836354

Filing Metadata

Form type: 4
Filed: Mar 5, 7:00 PM ET
Accepted: Mar 6, 4:13 PM ET
Size: 5.5 KB

View on SEC.gov